8-K: Chemours Q3 2025: Opteon Drives Growth Amid Market Weakness

The Chemours Company reported flat net sales in Q3 2025, with strong Opteon refrigerant demand offsetting weakness in other segments and operational disruptions.

Summary

• Net Sales for Q3 2025 were $1.5 billion, flat compared to the prior-year quarter, but decreased 7% sequentially.
• Net Income attributable to Chemours was $60 million, or $0.40 per diluted share, a significant improvement from a Net Loss of $32 million, or $(0.22) per diluted share, in Q3 2024.
• Adjusted Net Income for Q3 2025 was $30 million, or $0.20 per diluted share, down from $61 million, or $0.40 per diluted share, in Q3 2024.
• Adjusted EBITDA was $195 million, a 3% decrease compared to $202 million in Q3 2024, and a 23% decrease sequentially.
• Thermal & Specialized Solutions (TSS) segment Net Sales increased 20% to $560 million, with Adjusted EBITDA up 40% to $194 million, primarily driven by 80% year-over-year growth in Opteon Refrigerants.
• Titanium Technologies (TT) segment Net Sales decreased 9% to $612 million, and Adjusted EBITDA decreased 68% to $25 million, attributed to an 8% price decrease and $11 million in operational disruption costs.
• Advanced Performance Materials (APM) segment Net Sales decreased 12% to $311 million, and Adjusted EBITDA decreased 63% to $14 million, impacted by a resolved outage at the Washington Works site and $20 million in related costs.
• Free Cash Flow for Q3 2025 was $105 million, an increase from $63 million in the prior-year quarter, with a Free Cash Flow Conversion of 54%.
• Consolidated gross debt stood at $4.2 billion as of September 30, 2025, with a net leverage ratio of approximately 4.6x on a trailing twelve-month Adjusted EBITDA basis.

Sentiment

Score: 6

Explanation: While Net Income improved and the TSS segment showed strong growth driven by Opteon, overall Adjusted EBITDA declined, and the TT and APM segments faced significant headwinds from market weakness and operational issues. The resolution of past outages is positive, but the Q4 outlook is seasonally weaker, indicating a mixed performance with some positive developments overshadowed by persistent challenges.

Positives

• Net Income attributable to Chemours turned positive to $60 million in Q3 2025 from a Net Loss of $32 million in Q3 2024.
• Thermal & Specialized Solutions (TSS) segment demonstrated strong performance with Net Sales increasing 20% and Adjusted EBITDA increasing 40% year-over-year.
• Opteon Refrigerants sales within the TSS segment grew 80% year-over-year, reflecting robust demand driven by the U.S. AIM Act transition for stationary air conditioning.
• Operational disruptions at the Advanced Performance Materials (APM) Washington Works site have been resolved, indicating improved stability.
• Corporate Expenses decreased by $15 million year-over-year, primarily due to lower costs associated with litigation activities.
• Free Cash Flow increased to $105 million in Q3 2025 from $63 million in Q3 2024, demonstrating improved cash generation.
• The net leverage ratio decreased sequentially to 4.6x as of September 30, 2025, from 4.7x as of June 30, 2025.
• Successful qualification of Chemours' two-phase immersion cooling fluid with Samsung Electronics, indicating product innovation and market penetration.
• Announced a strategic agreement with SRF Limited in India to support market needs for essential applications.

Negatives

• Consolidated Net Sales were flat year-over-year and decreased 7% sequentially, indicating overall market softness.
• Adjusted Net Income decreased to $30 million in Q3 2025 from $61 million in Q3 2024.
• Adjusted EBITDA decreased 3% year-over-year to $195 million and 23% sequentially, reflecting broader challenges.
• Titanium Technologies (TT) segment experienced a 9% decrease in Net Sales and a substantial 68% decrease in Adjusted EBITDA year-over-year, primarily due to an 8% price decrease and $11 million in operational disruption costs.
• Advanced Performance Materials (APM) segment saw a 12% decrease in Net Sales and a 63% decrease in Adjusted EBITDA year-over-year, impacted by $20 million in outage-related costs and the final closure of the SPS Capstone product line.
• Overall volumes decreased 3% year-over-year, driven by the APM outage and demand weakness in industrial end markets.
• The broader macroeconomic environments in which the company operates continue to remain weak.
• TT segment lowered production volumes, resulting in increased fixed cost burden during the quarter, to align with near-term demand expectations.

Risks

• The outcome or resolution of any pending or future environmental liabilities, including those related to legacy PFAS.
• The commencement, outcome, or resolution of any regulatory inquiry, investigation, or proceeding.
• The initiation, outcome, or settlement of any litigation, including claims related to legacy PFAS liabilities.
• The ability to maintain effective internal control over financial reporting and disclosure controls and procedures.
• Changes in environmental regulations in the U.S. or other jurisdictions that affect demand for or adoption of products.
• Changes in regulations in the U.S. or other jurisdictions that could impose tariffs or additional costs on products.
• General economic conditions, geopolitical conditions, global health events, and weather events that may affect business and operations.
• Disruptions in supply chains, such as through strikes, labor disruptions, or other events.
• Adverse effects on business partners or a significant reduction in the demand for products.
• The inability to identify other risks at this time or those not currently expected to have a material impact on the business.

Future Outlook

For Q4 2025, consolidated Net Sales are anticipated to decrease 10-15% sequentially due to seasonal impacts, with consolidated Adjusted EBITDA expected to range between $130 million and $160 million. Corporate Expenses are projected to be $40 million to $45 million, and capital expenditures around $50 million, with Free Cash Flow Conversion between 50%-70%. The TSS segment expects a sequential Net Sales decrease in the high-teens to low-twenties percentage range, but anticipates continued double-digit Opteon growth to offset Freon declines, with Adjusted EBITDA between $125 million and $140 million. The TT segment forecasts a sequential Net Sales decrease in the high single-digits to low-teens percentage range, with Adjusted EBITDA between $15 million and $20 million, including a $25 million cost impact from production volume adjustments. The APM segment expects a low single-digit sequential Net Sales decrease, with Adjusted EBITDA between $30 million and $40 million, driven by a return to normal operations at Washington Works.

Management Comments

• "Our consolidated results exceeded our expectations for the quarter, driven by continued strong demand for Opteon products, paired with a focus on enhancing operational excellence, driving stability in our operations to resolve disruptions, and ensure improved performance going forward."
• "While the broader macroeconomic environments we participate in continue to remain weak, we are focused on our strategic pillar execution where we continue to make notable progress."
• "We are now seeing Opteon Refrigerants make up 80% of total combined refrigerant revenues, up from 58% from the prior-year quarter, and we feel well-positioned in the market as the transition to low GWP refrigerants continues to progress."
• "Operational matters have been resolved across our sites, which has been a key focus for the executive leadership team this quarter."

Industry Context

The U.S. AIM Act continues to drive a significant transition in the stationary air conditioning market towards lower global warming potential (GWP) refrigerants, directly benefiting Chemours' Opteon product line and the Thermal & Specialized Solutions (TSS) segment. Conversely, the global Titanium Dioxide (TiO2) market remains challenged, reflecting broader industrial demand weakness and pricing pressures that are impacting the Titanium Technologies (TT) segment. The overall macroeconomic environment is described as weak, affecting demand across various industrial end markets.

Comparison to Industry Standards

• NA

Legal Proceedings

• Litigation settlements, PFOA drinking water treatment accruals, and other related legal fees are ongoing.
• A $263 million charge is related to Chemours' portion of a settlement agreement with DuPont, Corteva, EID, and the State of New Jersey, reached in August 2025.
• An additional $12 million in third-party legal fees is directly related to the New Jersey settlement agreement.
• A $14 million charge is related to Chemours' portion of a settlement agreement to resolve the Hoosick Falls class action lawsuit.
• A $14 million charge is related to reserves for asbestos and production liability matters arising from an EID subsidiary, Sporting Goods Properties, Inc.
• Environmental charges primarily include changes to remediation reserves at four sites covered by the New Jersey settlement agreement and off-site remediation costs at Dordrecht Works.

Related Party Transactions

• Qualified spend recovery represents costs and expenses reimbursable by DuPont and/or Corteva as part of a cost-sharing agreement under the terms of a Memorandum of Understanding (MOU).
• Restricted cash of $52 million is held in escrow related to the MOU agreement with DuPont, Corteva, and EID for potential future legacy liabilities.

Stakeholder Impact

• Shareholders: Experienced positive GAAP Net Income, increased Free Cash Flow, but faced a decline in Adjusted Net Income and Adjusted EBITDA, alongside a cautious Q4 outlook. Dividends of $13 million were paid.
• Customers: Benefit from continued supply of Opteon refrigerants, the successful qualification of a new immersion cooling fluid with Samsung Electronics, and a strategic agreement with SRF Limited in India. A global TiO2 price increase is announced.
• Employees: Operational disruptions at key sites have been resolved, potentially improving working conditions and stability, though production adjustments in the TT segment may imply workforce considerations.
• Creditors: The company maintains a net leverage ratio of 4.6x and consolidated gross debt of $4.2 billion, with $1.6 billion in total liquidity.
• Regulatory Bodies: The company is navigating compliance with the U.S. AIM Act and managing ongoing environmental and litigation matters, including significant settlement agreements.

Next Steps

• A global TiO2 price increase will become effective on December 1, 2025.
• A conference call and webcast for Q3 2025 results is scheduled for November 7, 2025, at 8:00 AM Eastern Time.
• Continued investments in the TSS business are planned to develop liquid cooling and next-generation refrigerants.
• Ongoing focus on strategic pillar execution to drive improved performance.

Key Dates

Recommendation

The company presents a mixed financial picture. While the Thermal & Specialized Solutions (TSS) segment, particularly Opteon refrigerants, shows robust growth driven by regulatory tailwinds and strategic initiatives, the Titanium Technologies (TT) and Advanced Performance Materials (APM) segments are experiencing significant headwinds from market weakness, pricing pressures, and operational challenges. The resolution of past operational disruptions is a positive step towards stability. However, the overall Adjusted EBITDA declined, and the company continues to manage substantial legacy environmental liabilities and litigation. The Q4 outlook is seasonally weaker, suggesting continued volatility. Given these offsetting factors, a 'Hold' recommendation is appropriate as the positive momentum in one key area is balanced by persistent challenges in others, limiting clear upside in the near term without broader market recovery or further de-risking of liabilities.

Keywords

Chemours, CC, Q3 2025, financial results, earnings, Opteon, refrigerants, Titanium Dioxide, TiO2, Advanced Performance Materials, APM, Thermal & Specialized Solutions, TSS, chemicals, specialty chemicals, SEC filing, financial performance, PFAS, environmental liabilities, net sales, adjusted EBITDA, free cash flow, U.S. AIM Act